Tango has discarded one of its cancer drug on the dancefloor, after the USP1 inhibitor was linked to reports of liver toxicity in a phase 1 trial.
Related Keywords
Barbara Weber , Merck Co , Astrazeneca , Tango Therapeutics ,
comparemela.com © 2020. All Rights Reserved.